Abstract
Fifty-one children with Mediterranean spotted fever (MSF) were randomized to receive either clarithromycin, 15 mg/kg/day orally in 2 divided doses, or chloramphenicol, 50 mg/kg/day orally in 4 divided doses, for 7 days. Mean time to defervescence was 36.7 h in the clarithromycin group and 47.1 h in the chloramphenicol group (P=.047). Clarithromycin could be an acceptable therapeutic alternative to chloramphenicol and to tetracyclines for children aged <8 years with MSF
Lingua originale | English |
---|---|
pagine (da-a) | 409-411 |
Numero di pagine | 3 |
Rivista | Clinical Infectious Diseases |
Volume | 33 |
Stato di pubblicazione | Published - 2001 |
All Science Journal Classification (ASJC) codes
- ???subjectarea.asjc.2700.2726???
- ???subjectarea.asjc.2700.2725???